Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ildong Hyaltech is a specialized biotechnology company based in South Korea that focuses on the development and production of hyaluronic acid (HA) for medical and cosmetic use. A subsidiary of Ildong Holdings, the company leverages advanced fermentation and cross-linking technologies to manufacture high-purity HA raw materials and finished medical devices. Their core product line includes the Neobelle brand of dermal fillers and various viscoelastic solutions for orthopedic and ophthalmic applications. Ildong Hyaltech maintains state-of-the-art GMP manufacturing facilities and exports its products to numerous international markets. The company also offers contract development and manufacturing (CDMO) services, providing customized HA solutions to global pharmaceutical and aesthetic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ildong Hyaltech.